RX Note

APRIL 9, 2023

Introduction Clinical Pharmacology powered by ClinicalKey provides current, dependable drug information, including off-label indications, to guide treatment recommendations. Drug Class Overviews Provides information on therapeutic use, comparative efficacy, adverse reactions and drug interactions.

Clinical Pharmacology 52

Clinical Pharmacology Adverse Reactions Labelling 52

Big Molecule Watch

SEPTEMBER 25, 2023

Last week, FDA released a draft guidance, “ Labeling for Biosimilar and Interchangeable Biosimilar Products ” (“2023 Draft Guidance”) that—when finalized—will revise and replace its July 2018 final guidance, “ Labeling for Biosimilar Products.” The fictitious example provided in the 2023 Draft Guidance is “replicamab-cznm.”

Labelling 62

Labelling Biosimilars Adverse Reactions Dosage 62

pharmaphorum

MARCH 11, 2022

Vraylar, sold in some markets as Reagila, was first approved in 2015 for schizophrenia and bipolar disorder, with its label extended in 2017 to include maintenance treatment of schizophrenia and again in 2019 for bipolar depression.

Clinical Pharmacology 52

Clinical Pharmacology Labelling 52

PharmaShots

MARCH 9, 2023

and medical doctor in clinical pharmacology Other Affiliations: She is a member of the Board of Directors of L’Oréal S.A and Banco Bilbao Vizcaya Argentaria S.A LinkedIn Total experience: 16 yrs. Present company and time period: Johnson & Johnson (13 yrs.

Clinical Pharmacology 40

Clinical Pharmacology Immunity Immunization Pharmaceutical Companies 40

The Thyroid Pharmacist

DECEMBER 28, 2022

When it leaks into the bloodstream, the body does not recognize it, and labels the structure as a foreign invader and attacks it. Gluten can have a significant impact on the thyroid because of a phenomenon called molecular mimicry, which works like this: gluten can leak into the bloodstream, as it can create permeability in the gut barrier.

Immunity 110

Immunity Immunization Doctor of Pharmacy Clinical Pharmacology 110